Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC377

Tepotinib og lyfjafræðilega nothæf lausnarsambönd, sölt, ráphverfur og rúmhverfur þess

  • Status:
    Veitt
  • Application date:
    11.5.2022
  • Application published:
    15.6.2022
  • Grant published:
    15.9.2024
  • Max expiry date:
    28.4.2033
  • Medicine name:
    Tepmetko
  • Medicine for children:
    No

Timeline

Today
11.5.2022Application
15.6.2022Publication
15.9.2024Registration
28.4.2033Expires

Marketing license

  • IS authorization number:
    EU/1/21/1596/001
  • Date:
    22.2.2022
  • Foreign authorization number:
    EU/1/21/1596
  • Date:
    16.2.2022

Owner

  • Name:
    Merck Patent GmbH
  • Address:
    Frankfurter Strasse 250, Darmstadt DE

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Formgallafrestur, fyrsti

Deadline until: 18.08.2022

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 16.09.2024

Upload documents